About Us

Webcasts & Presentations

Neurocrine Biosciences’s management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. Webcast replays are typically available up to 30 days following any event. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com.

September 13, 2022

Neurocrine Biosciences to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Neurocrine Biosciences to Present at the Morgan Stanley 20th Annual Global  Healthcare Conference

Kevin Gorman, Chief Executive Officer, and Matt Abernethy, Chief Financial Officer, Will Present at the Conference
Tuesday September 13, 2022 at 10:35 a.m. Eastern Time in New York



For three decades, we have applied our unique insight into neuroscience to advance medicines for neurological, endocrine and psychiatric disorders. Our efforts have resulted in four FDA-approved therapies and a diverse, ambitious pipeline.

Learn More
Leadership Team

Our mission to relieve patient suffering begins with our leadership team. They lead our effort to relentlessly pursue medicines to ease the burden of debilitating diseases and disorders.

Learn More